share_log
Reuters ·  May 2 16:43
Lexicon Pharmaceuticals Inc - Revenues for First Quarter of 2024 Were $1.1 Million, Primarily From the Commercialization of Inpefa
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment